查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2065231

醫療保健區塊鏈市場預測至2034年—按組件、區塊鏈類型、部署模型、應用、最終用戶和地區分類的全球分析

Healthcare Blockchain Market Forecasts to 2034 - Global Analysis By Component (Platforms, Solutions, and Services), Blockchain Type, Deployment Mode, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球醫療保健區塊鏈市場預計將在 2026 年達到 14 億美元，到 2034 年達到 68 億美元，在預測期內以 21.7% 的複合年成長率成長。

醫療區塊鏈是指將分散式帳本技術 (DLT) 平台和解決方案應用於醫療生態系統中的挑戰，包括醫療資料管理、供應鏈完整性、臨床研究和金融交易處理。區塊鏈解決方案透過將交易記錄在防篡改、加密保護的帳本條目中，並在經批准的參與者網路上共用，即使在沒有建立互信關係的組織之間也能實現可靠的資料交換。

迫切需要安全可靠的醫療資料互通性和以病人為中心的病歷記錄。

全球醫療資訊系統碎片化，導致病患資料分散在互不相容的電子健康記錄(EHR) 平台、實驗室系統、藥局網路和影像庫中，造成醫療協調的重大缺口，並損害病患安全和臨床效率。區塊鏈無需集中式資料管理即可實現跨組織邊界的授權資料共用，因此作為以患者為中心的醫療記錄架構的基礎，正受到越來越多的關注。美國醫療保險和醫療補助服務中心 (CMS) 的互通性規則以及歐洲符合 GDPR 標準的跨境醫療數據共用框架等交換醫療資訊監管要求，獎勵各組織將區塊鏈視為實現可靠、長期訪問醫療記錄和保障患者數據主權的基礎技術。

區塊鏈網路的可擴展性限制和高能耗。

目前公共區塊鏈架構面臨根本性的可擴展性限制，難以處理大規模醫療保健應用所需的交易量。在區塊鏈環境中，每年處理數十億份醫療索賠、處方和電子健康記錄 (EHR) 存取交易需要大量的運算資源，而現有的共識機制無法有效應對。雖然私有區塊鏈和聯盟區塊鏈架構能夠提升企業級醫療保健應用的效能，但它們犧牲了部分去中心化和不可篡改性優勢，而這些優勢正是區塊鏈優於傳統資料庫解決方案的原因。此外，工作量證明 (PoW) 共識機制帶來的能源消耗問題，也引發了致力於環境責任的醫療保健機構對永續性的擔憂。

藥品供應鏈完整性及藥品真偽驗證應用

醫藥供應鏈是醫療保健區塊鏈最成熟、最具商業性可行性的短期應用領域之一。這主要得益於監管機構對藥品端到端可追溯性的要求，例如美國的《藥品供應鏈安全法案》和歐盟的《假藥指令》。區塊鏈平台能夠對藥品從生產商到患者的儲存和交付過程進行防篡改記錄，為相關人員提供檢驗的真偽記錄，並防止假藥流入市場。為滿足追蹤溯源合規性要求而建構的序列化和檢驗基礎設施構成了區塊鏈整合的基礎，製藥企業、批發商和藥房網路正在積極探索利用區塊鏈來增強供應鏈的透明度和事件回應能力。

監管的不確定性和缺乏標準化的區塊鏈管治框架

在大多數司法管轄區，基於區塊鏈的醫療保健解決方案的監管分類仍然模糊不清，這給開發和部署這些平台的機構帶來了法律上的不確定性。監管機構尚未明確解決去中心化網路中的數據主權、區塊鏈上記錄的健康數據的問責制，以及醫療設備法規在基於智慧合約的醫療保健功能中的適用性等問題。醫療保健區塊鏈聯盟缺乏標準化的管治，包括網路參與規則的共識機制、資料存取控制和爭議解決程序，這為多機構區塊鏈網路的建構帶來了實際障礙。這些監管和管治的不確定性導致風險規避型醫療保健公司在採用區塊鏈技術時持謹慎態度。

新型冠狀病毒（COVID-19）的影響：

新冠疫情暴露了醫療供應鏈和健康數據共用基礎設施的重大漏洞，而區塊鏈技術在解決這些問題方面具有獨特的優勢。個人防護工具（PPE）和疫苗供應鏈的中斷凸顯了關鍵醫療物資防篡改溯源的重要性。同時，分散的國際衛生數據系統也使疫情監測和跨境患者照護的協調變得更加複雜。多個國家實施的區塊鏈舉措，用於檢驗新冠疫苗接種記錄，展示了醫療數據認證的實際應用案例。這些疫情期間的應用案例提高了醫療系統管理人員和政府衛生機構對區塊鏈在醫療保健領域效用的認知，為疫情後加強對醫療保健區塊鏈基礎設施的投資奠定了基礎。

在預測期內，「解決方案」細分市場預計將佔據最大的市場佔有率。

在預測期內，「解決方案」細分市場預計將佔據最大的市場佔有率。供應鏈管理解決方案、臨床資料交換平台、身分管理工具和保險理賠處理應用程式共同貢獻了最大的收入，這反映了醫療機構的商業性優先事項是透過有針對性的區塊鏈部署來解決特定的、高價值的營運挑戰。隨著醫療機構透過初始解決方案部署累積區塊鏈實施經驗，他們正逐步將區塊鏈解決方案的應用擴展到相鄰領域，從而維持了該細分市場的強勁成長。 「解決方案」細分市場受益於經常性訂閱收入模式，該模式為區塊鏈平台供應商提供了可預測的收入來源。

預計在預測期內，聯盟型區塊鏈領域將呈現最高的複合年成長率。

在預測期內，聯盟區塊鏈領域預計將呈現最高的成長率。聯盟區塊鏈由特定的可信任醫療機構群體共同管理，例如保險公司、醫療服務提供者、製藥公司和監管機構，它在公共區塊鏈的去中心化和不可篡改性優勢與私有區塊鏈的性能和隱私管理優勢之間實現了最佳平衡。醫療產業聯盟正在開發共用資料交換網路、藥物追蹤溯源生態系統以及臨床試驗資料完整性保障平台，這些聯盟主要採用聯盟區塊鏈架構，使其成為醫療領域商業性最活躍的區塊鏈類型。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。美國在全球區塊鏈應用方面處於領先地位，這主要得益於其對藥品供應鏈嚴格的合規要求、高度發展的醫療資訊技術投資生態系統以及創業投資。美國主要的健康保險公司和藥品福利管理機構（PBM）正在探索利用區塊鏈技術實現理賠流程自動化和預核准，這構成了一個重要的商業需求群體。政府主導的舉措，例如美國國家衛生資訊科技協調中心（ 主導 ）的互通性法規和美國衛生與公眾服務部（HHS）的區塊鏈研究項目，也在加強美國醫療保健系統在醫療區塊鏈應用方面的機構知識基礎。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。中國的國家區塊鏈發展策略明確納入了醫療保健領域的具體應用，政府對基於區塊鏈的病歷系統和藥品供應鏈平台的投資正在推動市場活躍度。在印度，隨著「阿尤斯曼·巴拉特數位醫療計畫」（Ayushman Bharat Digital Mission）的推進，數位醫療基礎設施正在不斷擴展，這為整合基於區塊鏈的患者身分識別和健康記錄平台創造了機會。新加坡和韓國也透過公私合營計畫引領醫療保健領域的區塊鏈創新，使得亞太地區成為醫療保健區塊鏈應用領域成長最快速的區域市場。

免費客製化服務：

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球醫療保健區塊鏈市場：按組件分類

  • 平台
    • 區塊鏈基礎設施平台
    • 智慧合約平台
    • 互通性平台
  • 解決方案
    • 身分管理解決方案
    • 供應鏈管理解決方案
    • 臨床資料交換解決方案
    • 保險索賠和索賠管理解決方案
    • 詐欺檢測解決方案
  • 服務
    • 諮詢服務
    • 整合和配置服務
    • 支援和維護服務

第6章：全球醫療保健區塊鏈市場：以區塊鏈類型分類

  • 公共區塊鏈
  • 私有區塊鏈
  • 聯盟型區塊鏈
  • 混合區塊鏈

第7章：全球醫療保健區塊鏈市場：依部署模式分類

  • 基於雲端的
  • 現場
  • 混合實現

第8章：全球醫療保健區塊鏈市場：按應用領域分類

  • 臨床數據交換和互通性
  • 保險理賠的審核和處理
  • 供應鏈管理
  • 電子健康紀錄（EHR）
  • 臨床試驗和研究
  • 處方藥物管理
  • 身分和存取管理
  • 收入周期管理
  • 遠端患者監護
  • 醫療支付

第9章：全球醫療保健區塊鏈市場：以最終用戶分類

  • 醫療服務提供方
  • 醫療保健支付方
  • 製藥和生物技術公司
  • 醫療設備製造商
  • 研究機構
  • 病人和消費者

第10章：全球醫療保健區塊鏈市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • IBM Corporation
  • Microsoft Corporation
  • Oracle Corporation
  • SAP SE
  • Guardtime
  • BurstIQ
  • Hashed Health
  • Chronicled Inc.
  • Change Healthcare
  • Patientory Inc.
  • Solve.Care
  • Medicalchain SA
  • iSolve LLC
  • Factom
  • Hewlett Packard
Product Code: SMRC36789

According to Stratistics MRC, the Global Healthcare Blockchain Market is accounted for $1.4 billion in 2026 and is expected to reach $6.8 billion by 2034, growing at a CAGR of 21.7% during the forecast period. Healthcare Blockchain encompasses decentralized distributed ledger technology platforms and solutions applied to healthcare data management, supply chain integrity, clinical research, and financial transaction processing challenges within the medical ecosystem. By recording transactions in immutable, cryptographically secured ledger entries shared across a network of authorized participants, blockchain solutions enable trustworthy data exchange between organizations that lack established bilateral trust relationships.

Market Dynamics:

Driver:

Critical need for secure healthcare data interoperability and patient-centered records

The fragmented nature of global healthcare information systems, where patient data is distributed across incompatible EHR platforms, laboratory systems, pharmacy networks, and imaging repositories, creates significant care coordination gaps that compromise patient safety and clinical efficiency. Blockchain's capacity to enable permissioned data sharing across organizational boundaries without requiring centralized data custodianship is attracting growing interest as a foundation for patient-centered health record architectures. Regulatory mandates for healthcare information exchange, including CMS interoperability rules in the United States and GDPR-compliant cross-border health data sharing frameworks in Europe, are creating institutional incentives to explore blockchain as an enabling technology for trustworthy longitudinal health record access and patient data sovereignty.

Restraint:

Scalability limitations and high energy consumption of blockchain networks

Current public blockchain architectures face fundamental scalability constraints that limit their capacity to handle the transaction throughput volumes required by large-scale healthcare applications. Processing the billions of annual healthcare claims, medication dispensing events, and EHR access transactions within a blockchain environment demands computational resources that existing consensus mechanisms cannot efficiently accommodate. Private and consortium blockchain architectures offer improved performance for enterprise healthcare applications but sacrifice some of the decentralization and immutability benefits that justify blockchain's use over conventional database solutions. Energy consumption concerns associated with proof-of-work consensus mechanisms also raise sustainability questions relevant to healthcare organizations with environmental commitments.

Opportunity:

Pharmaceutical supply chain integrity and drug authentication applications

The pharmaceutical supply chain represents one of the most mature and commercially viable near-term application areas for healthcare blockchain, driven by regulatory requirements for end-to-end drug traceability including the U.S. Drug Supply Chain Security Act and the EU Falsified Medicines Directive. Blockchain platforms enable immutable documentation of drug custody transfers from manufacturer to patient, providing stakeholders with verifiable authenticity records that combat counterfeit medication infiltration. The serialization and verification infrastructure being built to satisfy track-and-trace compliance requirements creates a foundation for blockchain integration that pharmaceutical manufacturers, wholesalers, and pharmacy networks are actively exploring to enhance supply chain visibility and incident response capabilities.

Threat:

Regulatory uncertainty and lack of standardized blockchain governance frameworks

The regulatory classification of blockchain-based healthcare solutions remains ambiguous across most jurisdictions, creating legal uncertainty for organizations developing and deploying these platforms. Questions surrounding data sovereignty in decentralized networks, liability allocation for blockchain-recorded health data, and the application of medical device regulations to smart contract-based healthcare functions have not been definitively resolved by regulators. The absence of standardized governance frameworks for healthcare blockchain consortia, including consensus mechanisms for network participation rules, data access controls, and dispute resolution procedures, creates practical obstacles to multi-organizational blockchain network formation. These regulatory and governance uncertainties are contributing to cautious adoption among risk-averse healthcare enterprises.

Covid-19 Impact:

The COVID-19 pandemic exposed critical vulnerabilities in healthcare supply chains and health data sharing infrastructure that blockchain technology is uniquely positioned to address. PPE and vaccine supply chain disruptions highlighted the value of immutable provenance tracking for critical medical supplies, while fragmented international health data systems complicated pandemic surveillance and cross-border patient care coordination. Several blockchain initiatives for COVID-19 vaccination record verification were implemented across multiple countries, demonstrating practical health data credentialing applications. These pandemic-era use cases have raised awareness of blockchain's healthcare utility among health system executives and government health agencies, providing a foundation for expanded post-pandemic investment in healthcare blockchain infrastructure.

The Solutions segment is expected to be the largest during the forecast period

The Solutions segment is expected to account for the largest market share during the forecast period. Supply chain management solutions, clinical data exchange platforms, identity management tools, and claims processing applications collectively generate the highest revenue contribution, reflecting the commercial priority healthcare organizations place on addressing specific, high-value operational pain points through targeted blockchain deployments. As healthcare organizations gain blockchain implementation experience through initial solution deployments, they are progressively expanding their use of blockchain solutions into adjacent application areas, sustaining strong segment growth. The solutions segment benefits from recurring subscription revenue models that provide predictable income streams for blockchain platform vendors.

The Consortium Blockchain segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Consortium Blockchain segment is predicted to witness the highest growth rate. Consortium blockchains, governed jointly by a defined group of trusted healthcare organizations including payers, providers, pharmaceutical companies, and regulatory bodies, offer an optimal balance between the decentralization and immutability benefits of public blockchains and the performance and privacy control advantages of private implementations. Healthcare industry consortia developing shared data exchange networks, pharmaceutical track-and-trace ecosystems, and clinical trial data integrity platforms are predominantly adopting consortium blockchain architectures, making this model the most commercially active blockchain type within the healthcare sector.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. The United States leads global adoption driven by substantial pharmaceutical supply chain compliance mandates, a highly developed health IT investment ecosystem, and active venture capital funding of healthcare blockchain startups. Major U.S. health insurers and pharmacy benefit managers exploring blockchain for claims processing and prior authorization automation represent a significant commercial demand segment. Government initiatives including ONC interoperability regulations and HHS blockchain research programs are also advancing the institutional knowledge base for healthcare blockchain implementation across the American healthcare system.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. China's national blockchain development strategy includes explicit healthcare applications, and government investment in blockchain-based health record systems and pharmaceutical supply chain platforms is generating growing market activity. India's expanding digital health infrastructure under the Ayushman Bharat Digital Mission is creating integration opportunities for blockchain-based patient identity and health record platforms. Singapore and South Korea are also leading blockchain healthcare innovation through government-industry collaboration programs, making Asia Pacific the most dynamically growing regional market for healthcare blockchain deployment.

Key players in the market

Some of the key players in Global Healthcare Blockchain Market include IBM Corporation, Microsoft Corporation, Oracle Corporation, SAP SE, Guardtime, BurstIQ, Hashed Health, Chronicled Inc., Change Healthcare, Patientory Inc., Solve.Care, Medicalchain SA, iSolve LLC, Factom, and Hewlett Packard.

Key Developments:

In January 2026, IBM Corporation announced the expansion of its IBM Blockchain Platform for healthcare supply chain management, incorporating new serialized drug traceability modules aligned with DSCSA 2026 compliance requirements. The enhanced platform enables pharmaceutical manufacturers and wholesale distributors to achieve end-to-end electronic drug product verification across their supply chains, leveraging IBM's distributed ledger infrastructure to provide immutable custody transfer records accessible to all authorized supply chain participants.

In February 2026, Microsoft Corporation announced a partnership with a consortium of major U.S. health insurers to pilot a blockchain-based prior authorization interoperability network built on Microsoft Azure's distributed ledger services. The pilot aims to demonstrate the feasibility of automating prior authorization decisions through smart contracts that execute against shared eligibility and clinical criteria data, targeting a significant reduction in administrative burden and authorization processing time for both payers and healthcare providers.

Components Covered:

  • Platforms
  • Solutions
  • Services

Blockchain Types Covered:

  • Public Blockchain
  • Private Blockchain
  • Consortium Blockchain
  • Hybrid Blockchain

Deployment Modes Covered:

  • Cloud-Based
  • On-Premises
  • Hybrid Deployment

Applications Covered:

  • Clinical Data Exchange & Interoperability
  • Claims Adjudication and Billing
  • Supply Chain Management
  • Electronic Health Records (EHR)
  • Clinical Trials and Research
  • Prescription Drug Management
  • Identity and Access Management
  • Revenue Cycle Management
  • Remote Patient Monitoring
  • Healthcare Payments

End Users Covered:

  • Healthcare Providers
  • Healthcare Payers
  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Research Organizations
  • Patients and Consumers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Healthcare Blockchain Market, By Component

  • 5.1 Platforms
    • 5.1.1 Blockchain infrastructure platforms
    • 5.1.2 Smart contract platforms
    • 5.1.3 Interoperability platforms
  • 5.2 Solutions
    • 5.2.1 Identity management solutions
    • 5.2.2 Supply chain management solutions
    • 5.2.3 Clinical data exchange solutions
    • 5.2.4 Claims and billing management solutions
    • 5.2.5 Fraud detection solutions
  • 5.3 Services
    • 5.3.1 Consulting services
    • 5.3.2 Integration and deployment services
    • 5.3.3 Support and maintenance services

6 Global Healthcare Blockchain Market, By Blockchain Type

  • 6.1 Public Blockchain
  • 6.2 Private Blockchain
  • 6.3 Consortium Blockchain
  • 6.4 Hybrid Blockchain

7 Global Healthcare Blockchain Market, By Deployment Mode

  • 7.1 Cloud-Based
  • 7.2 On-Premises
  • 7.3 Hybrid Deployment

8 Global Healthcare Blockchain Market, By Application

  • 8.1 Clinical Data Exchange & Interoperability
  • 8.2 Claims Adjudication and Billing
  • 8.3 Supply Chain Management
  • 8.4 Electronic Health Records (EHR)
  • 8.5 Clinical Trials and Research
  • 8.6 Prescription Drug Management
  • 8.7 Identity and Access Management
  • 8.8 Revenue Cycle Management
  • 8.9 Remote Patient Monitoring
  • 8.10 Healthcare Payments

9 Global Healthcare Blockchain Market, By End User

  • 9.1 Healthcare Providers
  • 9.2 Healthcare Payers
  • 9.3 Pharmaceutical & Biotechnology Companies
  • 9.4 Medical Device Companies
  • 9.5 Research Organizations
  • 9.6 Patients and Consumers

10 Global Healthcare Blockchain Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 IBM Corporation
  • 13.2 Microsoft Corporation
  • 13.3 Oracle Corporation
  • 13.4 SAP SE
  • 13.5 Guardtime
  • 13.6 BurstIQ
  • 13.7 Hashed Health
  • 13.8 Chronicled Inc.
  • 13.9 Change Healthcare
  • 13.10 Patientory Inc.
  • 13.11 Solve.Care
  • 13.12 Medicalchain SA
  • 13.13 iSolve LLC
  • 13.14 Factom
  • 13.15 Hewlett Packard

List of Tables

  • Table 1 Global Healthcare Blockchain Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Healthcare Blockchain Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global Healthcare Blockchain Market Outlook, By Platforms (2023-2034) ($MN)
  • Table 4 Global Healthcare Blockchain Market Outlook, By Blockchain infrastructure platforms (2023-2034) ($MN)
  • Table 5 Global Healthcare Blockchain Market Outlook, By Smart contract platforms (2023-2034) ($MN)
  • Table 6 Global Healthcare Blockchain Market Outlook, By Interoperability platforms (2023-2034) ($MN)
  • Table 7 Global Healthcare Blockchain Market Outlook, By Solutions (2023-2034) ($MN)
  • Table 8 Global Healthcare Blockchain Market Outlook, By Identity management solutions (2023-2034) ($MN)
  • Table 9 Global Healthcare Blockchain Market Outlook, By Supply chain management solutions (2023-2034) ($MN)
  • Table 10 Global Healthcare Blockchain Market Outlook, By Clinical data exchange solutions (2023-2034) ($MN)
  • Table 11 Global Healthcare Blockchain Market Outlook, By Claims and billing management solutions (2023-2034) ($MN)
  • Table 12 Global Healthcare Blockchain Market Outlook, By Fraud detection solutions (2023-2034) ($MN)
  • Table 13 Global Healthcare Blockchain Market Outlook, By Services (2023-2034) ($MN)
  • Table 14 Global Healthcare Blockchain Market Outlook, By Consulting services (2023-2034) ($MN)
  • Table 15 Global Healthcare Blockchain Market Outlook, By Integration and deployment services (2023-2034) ($MN)
  • Table 16 Global Healthcare Blockchain Market Outlook, By Support and maintenance services (2023-2034) ($MN)
  • Table 17 Global Healthcare Blockchain Market Outlook, By Blockchain Type (2023-2034) ($MN)
  • Table 18 Global Healthcare Blockchain Market Outlook, By Public Blockchain (2023-2034) ($MN)
  • Table 19 Global Healthcare Blockchain Market Outlook, By Private Blockchain (2023-2034) ($MN)
  • Table 20 Global Healthcare Blockchain Market Outlook, By Consortium Blockchain (2023-2034) ($MN)
  • Table 21 Global Healthcare Blockchain Market Outlook, By Hybrid Blockchain (2023-2034) ($MN)
  • Table 22 Global Healthcare Blockchain Market Outlook, By Deployment Mode (2023-2034) ($MN)
  • Table 23 Global Healthcare Blockchain Market Outlook, By Cloud-Based (2023-2034) ($MN)
  • Table 24 Global Healthcare Blockchain Market Outlook, By On-Premises (2023-2034) ($MN)
  • Table 25 Global Healthcare Blockchain Market Outlook, By Hybrid Deployment (2023-2034) ($MN)
  • Table 26 Global Healthcare Blockchain Market Outlook, By Application (2023-2034) ($MN)
  • Table 27 Global Healthcare Blockchain Market Outlook, By Clinical Data Exchange & Interoperability (2023-2034) ($MN)
  • Table 28 Global Healthcare Blockchain Market Outlook, By Claims Adjudication and Billing (2023-2034) ($MN)
  • Table 29 Global Healthcare Blockchain Market Outlook, By Supply Chain Management (2023-2034) ($MN)
  • Table 30 Global Healthcare Blockchain Market Outlook, By Electronic Health Records (EHR) (2023-2034) ($MN)
  • Table 31 Global Healthcare Blockchain Market Outlook, By Clinical Trials and Research (2023-2034) ($MN)
  • Table 32 Global Healthcare Blockchain Market Outlook, By Prescription Drug Management (2023-2034) ($MN)
  • Table 33 Global Healthcare Blockchain Market Outlook, By Identity and Access Management (2023-2034) ($MN)
  • Table 34 Global Healthcare Blockchain Market Outlook, By Revenue Cycle Management (2023-2034) ($MN)
  • Table 35 Global Healthcare Blockchain Market Outlook, By Remote Patient Monitoring (2023-2034) ($MN)
  • Table 36 Global Healthcare Blockchain Market Outlook, By Healthcare Payments (2023-2034) ($MN)
  • Table 37 Global Healthcare Blockchain Market Outlook, By End User (2023-2034) ($MN)
  • Table 38 Global Healthcare Blockchain Market Outlook, By Healthcare Providers (2023-2034) ($MN)
  • Table 39 Global Healthcare Blockchain Market Outlook, By Healthcare Payers (2023-2034) ($MN)
  • Table 40 Global Healthcare Blockchain Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 41 Global Healthcare Blockchain Market Outlook, By Medical Device Companies (2023-2034) ($MN)
  • Table 42 Global Healthcare Blockchain Market Outlook, By Research Organizations (2023-2034) ($MN)
  • Table 43 Global Healthcare Blockchain Market Outlook, By Patients and Consumers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.